Get started
Author

Chris E. Holmes

Observed names: C. E. HOLMES, C. E. Holmes, C. Holmes, C.E. HOLMES, C.E. Holmes, Chris E Holmes, Chris E. HOlmes, Chris Holmes
ORCID: 0000-0003-0633-7571
Observed ORCID: 0000-0003-0633-7571
OpenAlex ID: A5013169333
The platelet contribution to cancer progression
2010 · N.M. BAMBACE, C.E. HOLMES · Journal of Thrombosis and Haemostasis · 706
Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer
2013 · Deva Sharma, Kathleen E. Brummel‐Ziedins, et al. · Journal of Cellular Physiology · 212
Platelets, coagulation and fibrinolysis in breast cancer progression
2013 · Inder Lal, Kim Dittus, et al. · Breast Cancer Research · 158
PDF
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer
2023 · Deborah Schrag, Hajime Uno, et al. · JAMA · 146
PDF
Correlates of Anemia in American Blacks and Whites: The REGARDS Renal Ancillary Study
2008 · N. A. Zakai, L. A. McClure, et al. · American Journal of Epidemiology · 101
PDF
The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets
2010 · Nadia M. Bambace, Jamie E. Levis, et al. · Platelets · 94
Platelet count and the risk for thrombosis and death in the elderly
2008 · J.G. Van der bom, S.R. Heckbert, et al. · Journal of Thrombosis and Haemostasis · 93
Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer
2015 · S. Ades, S. Kumar, et al. · Journal of Thrombosis and Haemostasis · 89
Characterization of iron(II).cntdot.bleomycin-mediated RNA strand scission
1993 · Chris E. Holmes, Barbara J. Carter, et al. · Biochemistry · 78
Lymphocytes, Lymphokines, and Silicosis
2001 · Gerald S. Davis, Chris E. Holmes, et al. · Journal of Environmental Pathology Toxicology and Oncology · 67
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis
2009 · C. E. Holmes, J. E. Levis, et al. · Clinical & Experimental Metastasis · 65
Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic
2020 · Chris E. Holmes, Steven Ades, et al. · JCO Oncology Practice · 56
PDF
Regional variation and cost implications of prescribed extended half‐life factor concentrates among U.S. Haemophilia Treatment Centres for patients with moderate and severe haemophilia
2019 · Stacy E. Croteau, Dunlei Cheng, et al. · Haemophilia · 44
Tamoxifen and Aromatase Inhibitors Differentially Affect Vascular Endothelial Growth Factor and Endostatin Levels in Women with Breast Cancer
2008 · Chris E. Holmes, Joe C. Huang, et al. · Clinical Cancer Research · 40
Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study
2022 · Ximena Jordan Bruno, Insu Koh, et al. · Journal of Thrombosis and Haemostasis · 39
The minor allele of GP6 T13254C is associated with decreased platelet activation and a reduced risk of recurrent cardiovascular events and mortality: results from the SMILE–Platelets project
2010 · J.D. SNOEP, P. GAUSSEM, et al. · Journal of Thrombosis and Haemostasis · 38
Platelet phenotype changes associated with breast cancer and its treatment
2016 · Chris E. Holmes, Jamie E. Levis, et al. · Platelets · 37
A multidisciplinary quality improvement program increases the inferior vena cava filter retrieval rate
2016 · John P Winters, Christopher S Morris, et al. · Vascular Medicine · 35
On the chemistry of RNA degradation by Fe·bleomycin
1997 · Chris E. Holmes, Robert J. Duff, et al. · Bioorganic & Medicinal Chemistry · 35
Efficacy of a short course of complex lymphedema therapy or graduated compression stocking therapy in the treatment of post-thrombotic syndrome
2014 · Chris E Holmes, Nadia M Bambace, et al. · Vascular Medicine · 28
PDF
Fe.bleomycin as a probe of RNA conformation
1996 · C. Holmes · Nucleic Acids Research · 26
PDF
The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial.
2021 · Deborah Schrag, Hajime Uno, et al. · Journal of Clinical Oncology · 24
Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study
2019 · Daniel R. Douce, Chris E. Holmes, et al. · Journal of Thrombosis and Haemostasis · 24
PDF
Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis
2022 · Steven Ades, Bhargavi Pulluri, et al. · Cancer Medicine · 15
PDF
The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy
2008 · Chris E. Holmes, Joe C. Huang, et al. · Journal of Thrombosis and Thrombolysis · 15
Works count: 86
Citation count: 2,475
H-index: 23
I10-index: 35
Year
Topic
Type